La maladie de Parkinson au Canada (serveur d'exploration)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthroid rats

Identifieur interne : 003D47 ( Main/Exploration ); précédent : 003D46; suivant : 003D48

NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthroid rats

Auteurs : B. C Figueiredo [Canada] ; L. Hu [Canada] ; A. M Bedard [Canada] ; W. Tetzlaff [Canada] ; A. Claudio Cuello [Canada]

Source :

RBID : ISTEX:BF56F5732E5FAA3181A881D4BAAF85E4C44BDD2F

Abstract

We have tested the hypotheses that nerve growth factor treatment in adult post-hypothyroid rats can: (1) restore cross-sectional area of cholinergic cells of the nucleus basalis and (2) prevent further atrophy of these neurons following cortical infaction. In addition, we assessed the expression of p75NGFR and p140trkA mRNAs in the nucleus basalis cells of post-hypothyroid rats. Rats were rendered hypothyroid by the addition of propylthiouracil to their diet beginning on embryonic day 19 until the age of 1 month. At this time both the pups and their dams continued to receive 0.05% propylthiouracil in their diet and the pups were thyroidectomized. At 60 days, propylthiouracil treatment was interrupted and thyroxine levels were restored to normal by daily subcutaneous administration of physiological levels of thyroxine. Morphometric analysis identified atrophied nucleus basalis magnocellularis cholinergic cells at two ages, days 75 and 105, identified by in situ hybridization for p75NGFR and p140trkA mRNAs in methylene blue stained cells (day 75) and choline acetyltransferase immunostaining (day 105). The mean number of silver grains (pixels) per μm2 (mean±S.E.M.) of cell body cross-sectional area for p75NGFR mRNA in the nucleus basalis magnocellularis of euthyroid rats was 3.43±0.89, which was not statistically different from post-hypothyroid animals (4.02±1.07). A similar finding was noted for p140trkA mRNA: mean number of grains in the euthyroid group was 5.54±0.96 and was not statistically different from the post-hypothyroid group (6.32±1.45). Nerve growth factor treatment in adulthood (between days 75 and 82) did not restore cross-sectional area from early thyroid deprivation. However, it prevented further atrophy of nucleus basalis magnocellularis neurons following cortical devascularization inflicted in adulthood (day 75).

Url:
DOI: 10.1016/S0891-0618(96)00171-8


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthroid rats</title>
<author>
<name sortKey="Figueiredo, B C" sort="Figueiredo, B C" uniqKey="Figueiredo B" first="B. C" last="Figueiredo">B. C Figueiredo</name>
</author>
<author>
<name sortKey="Hu, L" sort="Hu, L" uniqKey="Hu L" first="L" last="Hu">L. Hu</name>
</author>
<author>
<name sortKey="Bedard, A M" sort="Bedard, A M" uniqKey="Bedard A" first="A. M" last="Bedard">A. M Bedard</name>
</author>
<author>
<name sortKey="Tetzlaff, W" sort="Tetzlaff, W" uniqKey="Tetzlaff W" first="W" last="Tetzlaff">W. Tetzlaff</name>
</author>
<author>
<name sortKey="Cuello, A Claudio" sort="Cuello, A Claudio" uniqKey="Cuello A" first="A. Claudio" last="Cuello">A. Claudio Cuello</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BF56F5732E5FAA3181A881D4BAAF85E4C44BDD2F</idno>
<date when="1996" year="1996">1996</date>
<idno type="doi">10.1016/S0891-0618(96)00171-8</idno>
<idno type="url">https://api-v5.istex.fr/document/BF56F5732E5FAA3181A881D4BAAF85E4C44BDD2F/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002723</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">002723</idno>
<idno type="wicri:Area/Istex/Curation">002723</idno>
<idno type="wicri:Area/Istex/Checkpoint">001757</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">001757</idno>
<idno type="wicri:doubleKey">0891-0618:1996:Figueiredo B:ngf:prevents:further</idno>
<idno type="wicri:Area/Main/Merge">004437</idno>
<idno type="wicri:Area/Main/Curation">003D47</idno>
<idno type="wicri:Area/Main/Exploration">003D47</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthroid rats</title>
<author>
<name sortKey="Figueiredo, B C" sort="Figueiredo, B C" uniqKey="Figueiredo B" first="B. C" last="Figueiredo">B. C Figueiredo</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, McGill University, 3655 Drummond Street R-1325, Montreal, Quebec H3G 1Y6</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Hu, L" sort="Hu, L" uniqKey="Hu L" first="L" last="Hu">L. Hu</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, McGill University, 3655 Drummond Street R-1325, Montreal, Quebec H3G 1Y6</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Bedard, A M" sort="Bedard, A M" uniqKey="Bedard A" first="A. M" last="Bedard">A. M Bedard</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Physiology, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Tetzlaff, W" sort="Tetzlaff, W" uniqKey="Tetzlaff W" first="W" last="Tetzlaff">W. Tetzlaff</name>
<affiliation wicri:level="1">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Physiology, University of Ottawa, Ottawa, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Cuello, A Claudio" sort="Cuello, A Claudio" uniqKey="Cuello A" first="A. Claudio" last="Cuello">A. Claudio Cuello</name>
<affiliation wicri:level="4">
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Department of Pharmacology and Therapeutics, McGill University, 3655 Drummond Street R-1325, Montreal, Quebec H3G 1Y6</wicri:regionArea>
<orgName type="university">Université McGill</orgName>
<placeName>
<settlement type="city">Montréal</settlement>
<region type="state">Québec</region>
</placeName>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Journal of Chemical Neuroanatomy</title>
<title level="j" type="abbrev">CHENEU</title>
<idno type="ISSN">0891-0618</idno>
<imprint>
<publisher>ELSEVIER</publisher>
<date type="published" when="1996">1996</date>
<biblScope unit="volume">12</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="15">15</biblScope>
<biblScope unit="page" to="27">27</biblScope>
</imprint>
<idno type="ISSN">0891-0618</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0891-0618</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">We have tested the hypotheses that nerve growth factor treatment in adult post-hypothyroid rats can: (1) restore cross-sectional area of cholinergic cells of the nucleus basalis and (2) prevent further atrophy of these neurons following cortical infaction. In addition, we assessed the expression of p75NGFR and p140trkA mRNAs in the nucleus basalis cells of post-hypothyroid rats. Rats were rendered hypothyroid by the addition of propylthiouracil to their diet beginning on embryonic day 19 until the age of 1 month. At this time both the pups and their dams continued to receive 0.05% propylthiouracil in their diet and the pups were thyroidectomized. At 60 days, propylthiouracil treatment was interrupted and thyroxine levels were restored to normal by daily subcutaneous administration of physiological levels of thyroxine. Morphometric analysis identified atrophied nucleus basalis magnocellularis cholinergic cells at two ages, days 75 and 105, identified by in situ hybridization for p75NGFR and p140trkA mRNAs in methylene blue stained cells (day 75) and choline acetyltransferase immunostaining (day 105). The mean number of silver grains (pixels) per μm2 (mean±S.E.M.) of cell body cross-sectional area for p75NGFR mRNA in the nucleus basalis magnocellularis of euthyroid rats was 3.43±0.89, which was not statistically different from post-hypothyroid animals (4.02±1.07). A similar finding was noted for p140trkA mRNA: mean number of grains in the euthyroid group was 5.54±0.96 and was not statistically different from the post-hypothyroid group (6.32±1.45). Nerve growth factor treatment in adulthood (between days 75 and 82) did not restore cross-sectional area from early thyroid deprivation. However, it prevented further atrophy of nucleus basalis magnocellularis neurons following cortical devascularization inflicted in adulthood (day 75).</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
<region>
<li>Québec</li>
</region>
<settlement>
<li>Montréal</li>
</settlement>
<orgName>
<li>Université McGill</li>
</orgName>
</list>
<tree>
<country name="Canada">
<region name="Québec">
<name sortKey="Figueiredo, B C" sort="Figueiredo, B C" uniqKey="Figueiredo B" first="B. C" last="Figueiredo">B. C Figueiredo</name>
</region>
<name sortKey="Bedard, A M" sort="Bedard, A M" uniqKey="Bedard A" first="A. M" last="Bedard">A. M Bedard</name>
<name sortKey="Cuello, A Claudio" sort="Cuello, A Claudio" uniqKey="Cuello A" first="A. Claudio" last="Cuello">A. Claudio Cuello</name>
<name sortKey="Hu, L" sort="Hu, L" uniqKey="Hu L" first="L" last="Hu">L. Hu</name>
<name sortKey="Tetzlaff, W" sort="Tetzlaff, W" uniqKey="Tetzlaff W" first="W" last="Tetzlaff">W. Tetzlaff</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003D47 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003D47 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:BF56F5732E5FAA3181A881D4BAAF85E4C44BDD2F
   |texte=   NGF prevents further atrophy of cholinergic cells of the nucleus basalis due to cortical infarction in adult post-hypothyroid rats but does not restore cell size compared to euthroid rats
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022